• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcarePharmaceuticalsElite Pharmaceuticals
    Picture of Elite Pharmaceuticals logo

    ELTP — Elite Pharmaceuticals Share News

    $0.250.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousSmall CapContrarian
    • Market Cap
      $266.59m
    • Enterprise Value
      $231.80m
    • Revenue
      $148.87m
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • ELTP Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    ELTP Dividends
    • Brief: Elite Pharmaceuticals Receives Approval From FDA On May 16, For A Generic Version Of Methotrexate Sodium 2.5 Mg Tablets

      20/05/2024 23:48
    • Brief: Lannett Enters Into Distribution Agreement For Dantrolene Capsules

      28/06/2019 11:59
    • Brief: Lannett Enters Into Distribution Agreement For Generic Adderall

      11/03/2019 10:57
    • Brief: Elite Pharmaceuticals Gets FDA Approval For Generic Version Of Allergan's Pain Treatment Tablets

      20/11/2018 16:15
    • Brief: Elite Pharmaceuticals Files ANDA For Codeine And Acetaminophen Combo

      18/09/2018 16:32
    • Brief: Glenmark Pharmaceuticals Says Partner Elite Pharmaceuticals Got USFDA Nod For Methadone Hydrochloride Tablets

      07/08/2018 09:23
    • Brief: Elite reports on SequestOx FDA end-of-review meeting

      23/01/2017 13:18

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.